ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,186Medicare Part D Prescriptions Filled, Including Refills

Rank: 74 out of 939

$942K Total Retail Price of All Prescriptions

Rank: 55 out of 939

498 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 498 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

32% of this provider’s 498 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 11,530 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LISINOPRIL 776 556 1 3
HYDROCODONE-ACETAMINOPHEN 610 366 S3 2 1
LEVOTHYROXINE SODIUM 600 459 3 4
AMLODIPINE BESYLATE 543 438 4 6
OMEPRAZOLE 533 348 5 5
LOVASTATIN 517 324 6 46
METOPROLOL TARTRATE 470 286 7 10
GABAPENTIN 444 259 8 11
POTASSIUM CHLORIDE 412 344 9 9
SIMVASTATIN 407 334 10 2
FUROSEMIDE 392 278 11 7
PROAIR HFA 270 142 12 41
ZOLPIDEM TARTRATE 246 128 13 20
FENOFIBRATE 242 128 14 83
METOPROLOL SUCCINATE 239 159 15 21
LOSARTAN POTASSIUM 234 210 16 29
ALENDRONATE SODIUM 219 198 17 40
HYDROCHLOROTHIAZIDE 218 169 18 12
FLUTICASONE PROPIONATE 209 133 19 43
CARVEDILOL 204 160 20 25
ATORVASTATIN CALCIUM 203 121 21 22
CLOPIDOGREL 199 133 22 28
TRAMADOL HCL 199 115 22 16
METFORMIN HCL 198 107 24 8
FAMOTIDINE 188 156 25 62
MELOXICAM 186 100 26 14
FLUOXETINE HCL 179 117 27 47
WARFARIN SODIUM 161 107 28 17
LOVAZA 157 83 29 191
PLAVIX 151 113 30 48
ALLOPURINOL 148 99 31 31
DIOVAN 147 123 32 50
TAMSULOSIN HCL 138 123 33 27
PRAVASTATIN SODIUM 131 90 34 13
GLIMEPIRIDE 124 80 35 37
GLYBURIDE 123 75 R 36 89
NEXIUM 119 68 37 18
CITALOPRAM HBR 117 77 38 15
TRAZODONE HCL 109 58 39 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 108 67 40 23
SPIRIVA 107 65 41 73
KLOR-CON M20 105 72 42 90
ADVAIR DISKUS 101 59 43 60
EVISTA 100 90 44 122
CLONIDINE HCL 99 75 45 39
CEFDINIR 98 61 46 142
AZITHROMYCIN 96 53 47 32
DIGOXIN 90 79 48 45
SERTRALINE HCL 87 50 49 24
LIPITOR 87 70 49 127
ISOSORBIDE MONONITRATE ER 86 75 51 53
DONEPEZIL HCL 84 84 52 30
CYCLOBENZAPRINE HCL 79 18 R 53 36
PREDNISONE 77 50 54 42
POLYETHYLENE GLYCOL 3350 74 61 55 57
LOSARTAN-HYDROCHLOROTHIAZIDE 74 30 55 55
CIPROFLOXACIN HCL 69 48 57 54
VYTORIN 67 67 58 216
MECLIZINE HCL 66 47 59 134
DIOVAN HCT 66 54 59 74
ATENOLOL 65 59 61 19
SPIRONOLACTONE 65 27 61 71
RANEXA 64 42 63 248
VENLAFAXINE HCL ER 63 12 64 121
NIASPAN 63 32 64 183
BENAZEPRIL HCL 62 54 66 87
CRESTOR 61 39 67 34
LANTUS SOLOSTAR 60 30 68 128
TRICOR 59 44 69 143
OXYBUTYNIN CHLORIDE 58 47 70 125
TIZANIDINE HCL 58 42 70 81
PEN NEEDLE 57 37 72 193
GLIPIZIDE 56 34 73 52
SUCRALFATE 56 41 73 96
CELEBREX 55 35 75 106
CYMBALTA 53 22 76 44
TOPIRAMATE 53 12 76 154
NIFEDIPINE ER 53 31 76 105
NITROSTAT 53 35 76 204
NAMENDA 53 53 76 49
BUSPIRONE HCL 52 29 81 123
ESCITALOPRAM OXALATE 52 28 81 61
DILANTIN 50 30 83 324
ENABLEX 50 39 83 303
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.